カテゴリー： QYResearch, 世界

世界の乗り物酔い薬産業：成長傾向・競合分析2019-2025

【英語タイトル】Global Motion Sickness Drugs Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが出版した調査資料（DATA909X01556）・商品コード：DATA909X01556
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：119
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥725,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,087,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,450,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートでは、世界の乗り物酔い薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。乗り物酔い薬の種類別には、抗コリン薬、抗ヒスタミン薬、その他に、用途別には、大人、子供に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・乗り物酔い薬の種類別市場規模：抗コリン薬、抗ヒスタミン薬、その他
・乗り物酔い薬の用途別市場規模：大人、子供
・乗り物酔い薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール：GlaxoSmithKline、Prestige Brands、WellSpring Pharmaceutical Corporation、Baxter International、Mylan、Sandoz、Pfizer、Myungmoon Pharm、Caleb Pharmaceuticals
・市場規模予測2019-2025：生産量
・市場規模予測2019-2025：消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

Motion Sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness. In 2018, the global Motion Sickness Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Motion Sickness Drugs.

This study researches the market size of Motion Sickness Drugs, presents the global Motion Sickness Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Motion Sickness Drugs in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Motion Sickness Drugs for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Prestige Brands
WellSpring Pharmaceutical Corporation
Baxter International
Mylan
Sandoz
Pfizer
Myungmoon Pharm
Caleb Pharmaceuticals

Market Segment by Product Type
Anticholinergic
Antihistamines
Others

Market Segment by Application
Adults
Children

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Motion Sickness Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Motion Sickness Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Motion Sickness Drugs are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Motion Sickness Drugs Market Size Growth Rate by Type
1.3.2 Anticholinergic
1.3.3 Antihistamines
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Motion Sickness Drugs Market Share by Application (2019-2025)
1.4.2 Adults
1.4.3 Children
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Motion Sickness Drugs Market Size
2.1.1 Global Motion Sickness Drugs Revenue 2014-2025
2.1.2 Global Motion Sickness Drugs Sales 2014-2025
2.2 Motion Sickness Drugs Growth Rate by Regions
2.2.1 Global Motion Sickness Drugs Sales by Regions 2014-2019
2.2.2 Global Motion Sickness Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Motion Sickness Drugs Sales by Manufacturers
3.1.1 Motion Sickness Drugs Sales by Manufacturers 2014-2019
3.1.2 Motion Sickness Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Motion Sickness Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Motion Sickness Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Motion Sickness Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Motion Sickness Drugs Price by Manufacturers
3.4 Key Manufacturers Motion Sickness Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Motion Sickness Drugs Market
3.6 Key Manufacturers Motion Sickness Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Anticholinergic Sales and Revenue (2014-2019)
4.1.2 Antihistamines Sales and Revenue (2014-2019)
4.1.3 Others Sales and Revenue (2014-2019)
4.2 Global Motion Sickness Drugs Sales Market Share by Type
4.3 Global Motion Sickness Drugs Revenue Market Share by Type
4.4 Motion Sickness Drugs Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Motion Sickness Drugs Sales by Application

6 North America
6.1 North America Motion Sickness Drugs Breakdown Data by Company
6.2 North America Motion Sickness Drugs Breakdown Data by Type
6.3 North America Motion Sickness Drugs Breakdown Data by Application
6.4 North America Motion Sickness Drugs Breakdown Data by Countries
6.4.1 North America Motion Sickness Drugs Sales by Countries
6.4.2 North America Motion Sickness Drugs Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Motion Sickness Drugs Breakdown Data by Company
7.2 Europe Motion Sickness Drugs Breakdown Data by Type
7.3 Europe Motion Sickness Drugs Breakdown Data by Application
7.4 Europe Motion Sickness Drugs Breakdown Data by Countries
7.4.1 Europe Motion Sickness Drugs Sales by Countries
7.4.2 Europe Motion Sickness Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Motion Sickness Drugs Breakdown Data by Company
8.2 Asia Pacific Motion Sickness Drugs Breakdown Data by Type
8.3 Asia Pacific Motion Sickness Drugs Breakdown Data by Application
8.4 Asia Pacific Motion Sickness Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Motion Sickness Drugs Sales by Countries
8.4.2 Asia Pacific Motion Sickness Drugs Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Motion Sickness Drugs Breakdown Data by Company
9.2 Central & South America Motion Sickness Drugs Breakdown Data by Type
9.3 Central & South America Motion Sickness Drugs Breakdown Data by Application
9.4 Central & South America Motion Sickness Drugs Breakdown Data by Countries
9.4.1 Central & South America Motion Sickness Drugs Sales by Countries
9.4.2 Central & South America Motion Sickness Drugs Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Motion Sickness Drugs Breakdown Data by Type
10.2 Middle East and Africa Motion Sickness Drugs Breakdown Data by Application
10.3 Middle East and Africa Motion Sickness Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Motion Sickness Drugs Sales by Countries
10.3.2 Middle East and Africa Motion Sickness Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Motion Sickness Drugs
11.1.4 Motion Sickness Drugs Product Introduction
11.1.5 GlaxoSmithKline Recent Development
11.2 Prestige Brands
11.2.1 Prestige Brands Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Motion Sickness Drugs
11.2.4 Motion Sickness Drugs Product Introduction
11.2.5 Prestige Brands Recent Development
11.3 WellSpring Pharmaceutical Corporation
11.3.1 WellSpring Pharmaceutical Corporation Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Motion Sickness Drugs
11.3.4 Motion Sickness Drugs Product Introduction
11.3.5 WellSpring Pharmaceutical Corporation Recent Development
11.4 Baxter International
11.4.1 Baxter International Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Motion Sickness Drugs
11.4.4 Motion Sickness Drugs Product Introduction
11.4.5 Baxter International Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Motion Sickness Drugs
11.5.4 Motion Sickness Drugs Product Introduction
11.5.5 Mylan Recent Development
11.6 Sandoz
11.6.1 Sandoz Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Motion Sickness Drugs
11.6.4 Motion Sickness Drugs Product Introduction
11.6.5 Sandoz Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Motion Sickness Drugs
11.7.4 Motion Sickness Drugs Product Introduction
11.7.5 Pfizer Recent Development
11.8 Myungmoon Pharm
11.8.1 Myungmoon Pharm Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Motion Sickness Drugs
11.8.4 Motion Sickness Drugs Product Introduction
11.8.5 Myungmoon Pharm Recent Development
11.9 Caleb Pharmaceuticals
11.9.1 Caleb Pharmaceuticals Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Motion Sickness Drugs
11.9.4 Motion Sickness Drugs Product Introduction
11.9.5 Caleb Pharmaceuticals Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Motion Sickness Drugs Sales Channels
12.2.2 Motion Sickness Drugs Distributors
12.3 Motion Sickness Drugs Customers

13 Market Forecast
13.1 Global Motion Sickness Drugs Sales and Revenue Forecast 2019-2025
13.2 Global Motion Sickness Drugs Sales Forecast by Type
13.3 Global Motion Sickness Drugs Sales Forecast by Application
13.4 Motion Sickness Drugs Forecast by Regions
13.4.1 Global Motion Sickness Drugs Sales Forecast by Regions 2019-2025
13.4.2 Global Motion Sickness Drugs Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Motion Sickness Drugs Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Motion Sickness Drugs Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Motion Sickness Drugs Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Motion Sickness Drugs Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Motion Sickness Drugs Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Motion Sickness Drugs Product Picture
Table Motion Sickness Drugs Key Market Segments
Table Major Manufacturers Motion Sickness Drugs Covered in This Report
Table Global Motion Sickness Drugs Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Motion Sickness Drugs Sales Market Shar by Type 2014-2025
Figure Anticholinergic Figures
Table Major Manufacturers of Anticholinergic
Figure Antihistamines Figures
Table Major Manufacturers of Antihistamines
Figure Others Figures
Table Major Manufacturers of Others
Table Global Motion Sickness Drugs Market Share by Application 2019-2025 (K Units)
Figure Adults Use Case
Figure Children Use Case
Figure Motion Sickness Drugs Report Years Considered
Figure Global Motion Sickness Drugs Market Size 2014-2025 (Million US$)
Figure Global Motion Sickness Drugs Sales 2014-2019 (K Units)
Table Global Motion Sickness Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Motion Sickness Drugs Sales by Regions 2014-2019 (K Units)
Table Global Motion Sickness Drugs Sales Market Share by Regions 2014-2019
Figure Global Motion Sickness Drugs Sales Market Share by Regions 2014-2019
Figure Global Motion Sickness Drugs Sales Market Share by Regions in 2018
Table Global Motion Sickness Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Motion Sickness Drugs Revenue Market Share by Regions 2014-2019
Figure Global Motion Sickness Drugs Revenue Market Share by Regions 2014-2019
Figure Global Motion Sickness Drugs Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Motion Sickness Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Motion Sickness Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Motion Sickness Drugs Sales Share by Manufacturers in 2018
Table Motion Sickness Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Motion Sickness Drugs Revenue Share by Manufacturers (2014-2019)
Figure Motion Sickness Drugs Value Share by Manufacturers in 2018
Table Global Motion Sickness Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Motion Sickness Drugs Price (2014-2019) (USD/Unit)
Table Key Manufacturers Motion Sickness Drugs Plants/Factories Distribution
Table Key Manufacturers Motion Sickness Drugs Area Served
Table Date of Key Manufacturers Enter into Motion Sickness Drugs Market
Table Key Manufacturers Motion Sickness Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Anticholinergic Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Antihistamines Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Others Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Motion Sickness Drugs Sales by Type (2014-2019) (K Units)
Table Global Motion Sickness Drugs Sales Share by Type (2014-2019)
Figure Global Motion Sickness Drugs Sales Market Share by Type (2014-2019)
Figure Global Motion Sickness Drugs Sales Market Share by Type in 2018
Table Global Motion Sickness Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Motion Sickness Drugs Revenue Share by Type (2014-2019)
Figure Global Motion Sickness Drugs Revenue Market Share by Type (2014-2019)
Figure Global Motion Sickness Drugs Revenue Market Share by Type in 2018
Table Motion Sickness Drugs Price by Type 2014-2019 (USD/Unit)
Table Global Motion Sickness Drugs Sales by Application (2014-2019) (K Units)
Table Global Motion Sickness Drugs Sales Share by Application (2014-2019)
Figure Global Sales Motion Sickness Drugs Market Share by Application (2014-2019)
Figure Global Sales Motion Sickness Drugs Market Share by Application in 2018
Figure North America Motion Sickness Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Motion Sickness Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Motion Sickness Drugs Sales by Company (2014-2019) (K Units)
Table North America Motion Sickness Drugs Sales Market Share by Company (2014-2019)
Figure North America Motion Sickness Drugs Sales Market Share by Company in 2018
Table North America Motion Sickness Drugs Sales by Type (2014-2019) (K Units)
Table North America Motion Sickness Drugs Sales Market Share by Type (2014-2019)
Figure North America Motion Sickness Drugs Market Share by Type in 2018
Table North America Motion Sickness Drugs Sales by Application (2014-2019) (K Units)
Table North America Motion Sickness Drugs Sales Market Share by Application (2014-2019)
Figure North America Motion Sickness Drugs Market Share by Application in 2018
Table North America Motion Sickness Drugs Sales by Countries (2014-2019) (K Units)
Table North America Motion Sickness Drugs Sales Market Share by Countries (2014-2019)
Figure North America Motion Sickness Drugs Sales Market Share by Countries in 2018
Table North America Motion Sickness Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Motion Sickness Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Motion Sickness Drugs Revenue Market Share by Countries in 2018
Figure United States Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Europe Motion Sickness Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Motion Sickness Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Motion Sickness Drugs Sales by Company (2014-2019) (K Units)
Table Europe Motion Sickness Drugs Sales Market Share by Company (2014-2019)
Figure Europe Motion Sickness Drugs Sales Market Share by Company in 2018
Table Europe Motion Sickness Drugs Sales by Type (2014-2019) (K Units)
Table Europe Motion Sickness Drugs Sales Market Share by Type (2014-2019)
Figure Europe Motion Sickness Drugs Sales Market Share by Type in 2018
Table Europe Motion Sickness Drugs Sales by Application (2014-2019) (K Units)
Table Europe Motion Sickness Drugs Sales Market Share by Application (2014-2019)
Figure Europe Motion Sickness Drugs Sales Market Share by Application in 2018
Table Europe Motion Sickness Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Motion Sickness Drugs Sales Market Share by Countries (2014-2019)
Figure Europe Motion Sickness Drugs Sales Market Share by Countries in 2018
Table Europe Motion Sickness Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Motion Sickness Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Motion Sickness Drugs Revenue Market Share by Countries in 2018
Figure Germany Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Asia Pacific Motion Sickness Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Motion Sickness Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Motion Sickness Drugs Sales by Regions (2014-2019) (K Units)
Table Asia Pacific Motion Sickness Drugs Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Motion Sickness Drugs Sales Market Share by Regions in 2018
Table Asia Pacific Motion Sickness Drugs Sales by Type (2014-2019) (K Units)
Table Asia Pacific Motion Sickness Drugs Sales Market Share by Type (2014-2019)
Figure Asia Pacific Motion Sickness Drugs Market Share by Type in 2018
Table Asia Pacific Motion Sickness Drugs Sales by Application (2014-2019) (K Units)
Table Asia Pacific Motion Sickness Drugs Sales Market Share by Application (2014-2019)
Figure Asia Pacific Motion Sickness Drugs Market Share by Application in 2018
Table Asia Pacific Motion Sickness Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Motion Sickness Drugs Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Motion Sickness Drugs Sales Market Share by Regions in 2018
Table Asia Pacific Motion Sickness Drugs Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Motion Sickness Drugs Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Motion Sickness Drugs Revenue Market Share by Regions in 2018
Figure China Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Motion Sickness Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Motion Sickness Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Motion Sickness Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Motion Sickness Drugs Sales by Company (2014-2019) (K Units)
Table Central & South America Motion Sickness Drugs Sales Market Share by Company (2014-2019)
Figure Central & South America Motion Sickness Drugs Sales Market Share by Company in 2018
Table Central & South America Motion Sickness Drugs Sales by Type (2014-2019) (K Units)
Table Central & South America Motion Sickness Drugs Sales Market Share by Type (2014-2019)
Figure Central & South America Motion Sickness Drugs Market Share by Type in 2018
Table Central & South America Motion Sickness Drugs Sales by Application (2014-2019) (K Units)
Table Central & South America Motion Sickness Drugs Sales Market Share by Application (2014-2019)
Figure Central & South America Motion Sickness Drugs Market Share by Application in 2018
Table Central & South America Motion Sickness Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Motion Sickness Drugs Sales Market Share by Countries (2014-2019)
Figure Central & South America Motion Sickness Drugs Sales Market Share by Countries in 2018
Table Central & South America Motion Sickness Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Motion Sickness Drugs Revenue Market Share by Countries (2014-2019)
Figure Central & South America Motion Sickness Drugs Revenue Market Share by Countries in 2018
Figure Brazil Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Motion Sickness Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Middle East and Africa Motion Sickness Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Motion Sickness Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Motion Sickness Drugs Sales by Type (2014-2019) (K Units)
Table Middle East and Africa Motion Sickness Drugs Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Motion Sickness Drugs Sales Market Share by Type in 2018
Table Middle East and Africa Motion Sickness Drugs Sales by Application (2014-2019) (K Units)
Table Middle East and Africa Motion Sickness Drugs Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Motion Sickness Drugs Sales Market Share by Application in 2018
Table Middle East and Africa Motion Sickness Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Motion Sickness Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Motion Sickness Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Motion Sickness Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Motion Sickness Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Motion Sickness Drugs Revenue Market Share by Countries in 2018
Figure GCC Countries Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Motion Sickness Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Egypt Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Motion Sickness Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure South Africa Motion Sickness Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Motion Sickness Drugs Revenue Growth Rate (2014-2019) (K Units)
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Motion Sickness Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Motion Sickness Drugs Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Motion Sickness Drugs Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table Prestige Brands Company Details
Table Prestige Brands Description and Business Overview
Table Prestige Brands Motion Sickness Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Prestige Brands Motion Sickness Drugs Sales Growth Rate (2014-2019)
Table Prestige Brands Motion Sickness Drugs Sales Market Share in Global Market
Table Prestige Brands Recent Development
Table WellSpring Pharmaceutical Corporation Company Details
Table WellSpring Pharmaceutical Corporation Description and Business Overview
Table WellSpring Pharmaceutical Corporation Motion Sickness Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table WellSpring Pharmaceutical Corporation Motion Sickness Drugs Sales Growth Rate (2014-2019)
Table WellSpring Pharmaceutical Corporation Motion Sickness Drugs Sales Market Share in Global Market
Table WellSpring Pharmaceutical Corporation Recent Development
Table Baxter International Company Details
Table Baxter International Description and Business Overview
Table Baxter International Motion Sickness Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Baxter International Motion Sickness Drugs Sales Growth Rate (2014-2019)
Table Baxter International Motion Sickness Drugs Sales Market Share in Global Market
Table Baxter International Recent Development
Table Mylan Company Details
Table Mylan Description and Business Overview
Table Mylan Motion Sickness Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mylan Motion Sickness Drugs Sales Growth Rate (2014-2019)
Table Mylan Motion Sickness Drugs Sales Market Share in Global Market
Table Mylan Recent Development
Table Sandoz Company Details
Table Sandoz Description and Business Overview
Table Sandoz Motion Sickness Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sandoz Motion Sickness Drugs Sales Growth Rate (2014-2019)
Table Sandoz Motion Sickness Drugs Sales Market Share in Global Market
Table Sandoz Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Motion Sickness Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Motion Sickness Drugs Sales Growth Rate (2014-2019)
Table Pfizer Motion Sickness Drugs Sales Market Share in Global Market
Table Pfizer Recent Development
Table Myungmoon Pharm Company Details
Table Myungmoon Pharm Description and Business Overview
Table Myungmoon Pharm Motion Sickness Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Myungmoon Pharm Motion Sickness Drugs Sales Growth Rate (2014-2019)
Table Myungmoon Pharm Motion Sickness Drugs Sales Market Share in Global Market
Table Myungmoon Pharm Recent Development
Table Caleb Pharmaceuticals Company Details
Table Caleb Pharmaceuticals Description and Business Overview
Table Caleb Pharmaceuticals Motion Sickness Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Caleb Pharmaceuticals Motion Sickness Drugs Sales Growth Rate (2014-2019)
Table Caleb Pharmaceuticals Motion Sickness Drugs Sales Market Share in Global Market
Table Caleb Pharmaceuticals Recent Development
Figure Motion Sickness Drugs Value Chain
Table Motion Sickness Drugs Distributors List
Table Motion Sickness Drugs Customers List
Table Global Motion Sickness Drugs Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure Global Motion Sickness Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Motion Sickness Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Motion Sickness Drugs Sales Forecast by Type 2019-2025 (K Units)
Figure Global Motion Sickness Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Motion Sickness Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Motion Sickness Drugs Sales Forecast by Application 2019-2025 (K Units)
Figure Global Motion Sickness Drugs Sales Market Share Forecast by Application 2019-2025
Table Global Motion Sickness Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Motion Sickness Drugs Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Motion Sickness Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Motion Sickness Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Motion Sickness Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Motion Sickness Drugs Revenue Market Share Forecast by Regions 2019-2025
Table North America Motion Sickness Drugs Sales Forecast by Countries 2019-2025 (K Units)
Table North America Motion Sickness Drugs Sales Market Share Forecast by Countries 2019-2025
Table North America Motion Sickness Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Motion Sickness Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure United States Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure Canada Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure Mexico Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Table Europe Motion Sickness Drugs Sales Forecast by Countries 2019-2025 (K Units)
Table Europe Motion Sickness Drugs Sales Market Share Forecast by Countries 2019-2025
Table Europe Motion Sickness Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Motion Sickness Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure France Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure UK Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure Italy Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure Russia Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Table Asia Pacific Motion Sickness Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Asia Pacific Motion Sickness Drugs Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Motion Sickness Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Motion Sickness Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure China Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure Japan Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure South Korea Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure India Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure Australia Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure Indonesia Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure Thailand Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure Malaysia Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure Philippines Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure Vietnam Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Table Central & South America Motion Sickness Drugs Sales Forecast by Countries 2019-2025 (K Units)
Table Central & South America Motion Sickness Drugs Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Motion Sickness Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Motion Sickness Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Table Middle East and Africa Motion Sickness Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Middle East and Africa Motion Sickness Drugs Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Motion Sickness Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Motion Sickness Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure GCC Countries Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure Egypt Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Figure South Africa Motion Sickness Drugs Sales Forecast 2019-2025 (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

GlaxoSmithKline、Prestige Brands、WellSpring Pharmaceutical Corporation、Baxter International、Mylan、Sandoz、Pfizer、Myungmoon Pharm、Caleb Pharmaceuticals

★調査レポート[世界の乗り物酔い薬産業：成長傾向・競合分析2019-2025] (コード：DATA909X01556)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の乗り物酔い薬産業：成長傾向・競合分析2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の抗コリン性乗物酔い防止薬産業：成長傾向・競合分析2019-2025
    DATA909X00132 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の抗コリン性乗物酔い防止薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。抗コリン性乗物酔い防止薬の種類別には、大人、子供に、用途別には、病院、ドラッグストア、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・抗コリン性乗物酔い防止薬の種類別市場規模：大人、子供 ・抗コリン性乗物酔い防止薬の用途別市場規模：病院、ドラッグストア、その他 ・抗コリン性乗物酔い防止薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：GlaxoSmithKline、Baxter International ・市場規模予測2019-2025：生産量...Travel Sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness. In 2018, the global Anticholinergic Travel Sickness Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025...
  • 世界の抗ヒスタミン薬産業：成長傾向・競合分析2019-2025
    DATA909X00136 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の抗ヒスタミン薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。抗ヒスタミン薬の種類別には、大人、子供に、用途別には、病院、ドラッグストア、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・抗ヒスタミン薬の種類別市場規模：大人、子供 ・抗ヒスタミン薬の用途別市場規模：病院、ドラッグストア、その他 ・抗ヒスタミン薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Prestige Brands、WellSpring Pharmaceutical...Travel Sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness. In 2018, the global Antihistamines Travel Sickness Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025...
  • 世界の眼瞼炎薬産業：成長傾向・競合分析2019-2025
    DATA909X00325 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の眼瞼炎薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。眼瞼炎薬の種類別には、ステロイド、抗生物質に、用途別には、クリニック、病院に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・眼瞼炎薬の種類別市場規模：ステロイド、抗生物質 ・眼瞼炎薬の用途別市場規模：クリニック、病院 ・眼瞼炎薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Akorn Inc.、Allergan Plc、Bausch...Blepharitis (blef-uh-RYE-tis) is inflammation of the eyelids. Blepharitis usually involves the part of the eyelid where the eyelashes grow and affects both eyelids.In 2018, the global Blepharitis Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Blepharitis Drugs. This study researches the market size of Blepharitis Drugs, presents the global Blepharitis Drugs sales and revenue by companies, regions, type and...
  • 世界の女性不妊症治療薬産業：成長傾向・競合分析2019-2025
    DATA909X00868 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の女性不妊症治療薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。女性不妊症治療薬の種類別には、非経口、経口、その他に、用途別には、不妊治療クリニック、病院、クライオバンクに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・女性不妊症治療薬の種類別市場規模：非経口、経口、その他 ・女性不妊症治療薬の用途別市場規模：不妊治療クリニック、病院、クライオバンク ・女性不妊症治療薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Allergan Plc、Ferring BV、Merck...Female Infertility Drugs are usually prescribed to women as they're mostly used to help with ovulation problems.In 2018, the global Female Infertility Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Female Infertility Drugs. This study researches the market size of Female Infertility Drugs, presents the global Female Infertility Drugs sales and revenue by companies, regions, type and application, history breakdown data from...
  • 世界の有毛細胞白血病治療産業：成長傾向・競合分析2019-2025
    DATA909X01057 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の有毛細胞白血病治療市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。有毛細胞白血病治療の種類別には、化学療法薬、標的阻害剤に、用途別には、クリニック、病院に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・有毛細胞白血病治療の種類別市場規模：化学療法薬、標的阻害剤 ・有毛細胞白血病治療の用途別市場規模：クリニック、病院 ・有毛細胞白血病治療の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：AstraZeneca Plc、F. Hoffmann-La...Hairy cell leukemia is a slow-growing, rare type of chronic cell leukemia.In 2018, the global Hairy Cell Leukemia Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hairy Cell Leukemia Drugs. This study researches the market size of Hairy Cell Leukemia Drugs, presents the global Hairy Cell Leukemia Drugs sales and revenue by companies, regions, type and application, history breakdown...
  • 世界の駆虫薬産業：成長傾向・競合分析2019-2025
    DATA909X00126 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の駆虫薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。駆虫薬の種類別には、経口薬、注射剤に、用途別には、人間用、動物用に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・駆虫薬の種類別市場規模：経口薬、注射剤 ・駆虫薬の用途別市場規模：人間用、動物用 ・駆虫薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Novartis、Pfizer、Bayer、Cipla、Sun Pharmaceutical Industries、Mankind...Anthelmintics are drugs that work on helminths as either vermicides (by killing) or vermifuges (by expelling).In 2018, the global Anthelmintic Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anthelmintic Drugs. This study researches the market size of Anthelmintic Drugs, presents the global Anthelmintic Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2014 to...
  • 世界の皮膚炎薬産業：成長傾向・競合分析2019-2025
    DATA909X00652 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の皮膚炎薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。皮膚炎薬の種類別には、カルシニューリン阻害剤、コルチコステロイド、生物製剤、その他に、用途別には、病院薬局、小売薬局、オンライン薬局に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・皮膚炎薬の種類別市場規模：カルシニューリン阻害剤、コルチコステロイド、生物製剤、その他 ・皮膚炎薬の用途別市場規模：病院薬局、小売薬局、オンライン薬局 ・皮膚炎薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Regeneron、Bausch Health、Astellas Pharma、Pfizer、Mylan、Bayer、Allergan、LEO...Dermatitis, also known as eczema, is a group of diseases that results in inflammation of the skin. These diseases are characterized by itchiness, red skin and a rash.In 2018, the global Dermatitis Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dermatitis Drugs. This study researches the market size of Dermatitis Drugs, presents the global Dermatitis Drugs sales and revenue by companies, regions, type and application, history breakdown...
  • 世界の乗物酔い薬産業：成長傾向・競合分析2019-2025
    DATA909X01292 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の乗物酔い薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。乗物酔い薬の種類別には、抗コリン薬、抗ヒスタミン薬、その他に、用途別には、大人、子供に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・乗物酔い薬の種類別市場規模：抗コリン薬、抗ヒスタミン薬、その他 ・乗物酔い薬の用途別市場規模：大人、子供 ・乗物酔い薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：GlaxoSmithKline、Prestige Brands、WellSpring Pharmaceutical...Kinetosis is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness. In 2018, the global Kinetosis Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast...
  • 世界の犬用処方薬産業：成長傾向・競合分析2019-2025
    DATA909X00706 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の犬用処方薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。犬用処方薬の種類別には、経口タイプ、塗抹タイプ、注射タイプ、スプレータイプに、用途別には、病院、診療所、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・犬用処方薬の種類別市場規模：経口タイプ、塗抹タイプ、注射タイプ、スプレータイプ ・犬用処方薬の用途別市場規模：病院、診療所、その他 ・犬用処方薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Elanco Animal Health、Ceva...Dog prescription drug is a kind of animal prescription. Animal prescription drug is a prescription drug used to prevent, treat, diagnose, or purposefully regulate an animal's physiology. Animal prescription drugs mainly include: serum products, vaccines, diagnostic products, micro-ecological products, chemicals, antibiotics, biochemical drugs, radioactive drugs and external insecticides, disinfectants, etc.In 2018, the global Dog Prescription Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate...

    • ◆H&Iグローバルリサーチのお客様（例）◆